Ticker: GSK CUSIP: 37733W204 Class: SPONSORED ADR
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 8,480,546 | $415,886 | — | — |
| Q3 2025 | 8,823,739 | $380,832 | — | — |
| Q2 2025 | 8,577,017 | $329,357 | — | — |
| Q1 2025 | 7,581,079 | $293,692 | — | — |
| Q4 2024 | 7,169,210 | $242,463 | — | — |
| Q3 2024 | 7,172,889 | $293,228 | — | — |
| Q2 2024 | 7,040,720 | $271,067 | — | — |
| Q1 2024 | 8,147,408 | $349,278 | — | — |
| Q4 2023 | 8,286,487 | $307,097 | — | — |
| Q3 2023 | 8,079,897 | $292,896 | — | — |
| Q2 2023 | 7,690,026 | $274,071 | — | — |
| Q1 2023 | 2,163,290 | $76,971 | — | — |
| Q4 2022 | 1,822,666 | $64,048 | — | — |
| Q3 2022 | 1,744,388 | $51,337 | — | — |